Search results
Shell pauses construction on major biofuels plant in Netherlands
PA Media: UK News via Yahoo News· 3 hours agoWael Sawan, Shell’s chief executive since January 2023, has overseen a raft of rollbacks in such...
Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Zacks via Yahoo News· 3 hours agoMesoblast Limited MESO has witnessed a phenomenal run in the year so far. Shares of MESO have risen...
Sunak correctly guesses price of Morrisons tiger bloomer, but does not know how much it has risen by
The Independent via Yahoo News· 6 hours agoRishi Sunak confidently answered a question about the price of bread ahead of the general election,...
When is the next UK general election? Britain set to head for the polls
Evening Standard via Yahoo News· 3 hours agoParty leaders, MPs and activists have spent weeks campaigning for voters, with attention-grabbing...
Nigeria weekend suicide bomb attack toll climbs to 32
AFP News via Yahoo News· 21 hours agoThe death toll from multiple suicide bombings in the northeastern Nigerian town of Gwoza over the...
Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner
Zacks via Yahoo News· 2 hours agoMerck (MRK) exercises the option that will convert the collaboration deal with partner Orion for...
Global stocks, euro slip ahead of major elections
AFP News via Yahoo News· 45 minutes agoGlobal stock markets slipped while the euro retreated Tuesday on concerns about the potential economic fallout should the far-right win power in France...
Biden claims Border Patrol endorsed him: Is that true?
The Hill via Yahoo News· 5 days agoDuring the first presidential debate of 2024, President Joe Biden and former President Donald Trump...
Intuitive Surgical (ISRG) Rises 10% in a Month: What's Next?
Zacks via Yahoo News· 2 hours agoIntuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing...
CHMP Endorses Moderna's (MRNA) mRNA-based RSV Vaccine
Zacks via Yahoo News· 1 day agoThe RSV vaccine is already approved by the FDA in May 2024, becoming Moderna’s second approved...